Kambe T, Yamasaki T, Yamamoto A, Nagoshi A, et al. Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy 
combined with degarelix acetate predicts the biochemical recurrence in patients 
with very high-risk prostate cancer who underwent robot-assisted radical 
prostatectomy. Int J Urol 2024 Sep 10. doi: 10.1111/iju.15579.
PMID: 39253858
|   |  |  | 
